Give your patients a reason to smile.

Wishbone Biotech's mission is to revolutionise bone regeneration for dental implants by providing superior bone graft substitute products using innovative technologies and forward-thinking clinical approaches. 

We extract and deactivate all proteins, including prions, from our bovine bone graft using cutting-edge, patent-protected manufacturing technology. Our manufacturing process retains the natural micro and nano-topography of the native bone, enhances bone graft mineralization, and promotes effective implant osteointegration. We have named this groundbreaking product "W-Bone".

We are pleased to provide a state-of-the-art facility for Research and Development, Production, and Quality Control, located here in the province of Liège, Belgium. Our facility complies with ISO 13485 and has an ISO 7-certified cleanroom.

Leadership Team

  • Emilie Dory, CEO

    With a strong foundation in bioengineering, Emilie Dory began her career as an R&D engineer, contributing significantly to the development of Wishbone’s medical devices. Her deep understanding of both product development and regulatory frameworks has played a key role in guiding Wishbone’s growth and success in a highly competitive and regulated industry.

    Under Emilie’s leadership, Wishbone has become recognized for its cutting-edge bone regeneration technologies. She has successfully navigated the complex regulatory requirements of the medical device industry, ensuring the company’s products meet the highest standards. Her blend of technical expertise and regulatory insight has positioned Wishbone as a leading player in the field, expanding both its product offerings and market reach.

  • Justine Pirson, R&D Manager

    Justine Pirson holds a PhD in Molecular and Cellular Biology from the University of Liège, Belgium. With over six years of experience at Wishbone, she currently serves as the R&D Manager while also overseeing the company’s quality control operations. Her dual role ensures the development and refinement of Wishbone’s innovative bone graft substitutes for dental applications, while maintaining strict compliance with industry standards.

    Her work bridges research, development, and product safety, playing a critical role in ensuring that Wishbone’s products not only push technological boundaries but are also safe and reliable for clinical use.

    Her strong academic background, combined with her extensive hands-on experience at Wishbone, makes Justine a key figure in the company’s growth and its ability to bring innovative solutions to the field of bone regeneration.

  • Caroline Trus, QA/RA Manager

    Caroline Trus is the QA/RA Manager at Wishbone and holds a degree in Biomedical Engineering. With more than 8 years of experience in Quality Management and Regulatory Affairs within the medtech industry, she brings both technical expertise and a practical, strategic approach to regulatory processes. Caroline excels in understanding the complex requirements linked to QA/RA for medical devices, ensuring that compliance is met without slowing down operational efficiency.

    Her unique strength lies in transforming quality management into a tool for growth, using it to enhance the activities of Wishbone rather than treating it as a regulatory burden. Her background as a biomedical engineer further strengthens her ability to integrate scientific and technical insights into the company’s quality and regulatory strategies, ensuring that Wishbone’s innovative products not only meet but exceed industry standards.

The Founders

  • Eric Rompen

    Eric Rompen is a full-time Professor at the University of Liege and the head of the department of Periodontology – Dental Surgery. He is also coordinating the European University Certificate of oral implantology. His favorite subjects of clinical and experimental research are biomaterials, bone regeneration, biological interface implant/soft issue and osseointegration. His clinical work is focused on gingival muco surgery and implantology.

  • France Lambert

    France Lambert graduated from the University of Liege in Periodontology, where she continued to obtain a PhD in the same subject. She has also completed a fellowship program in oral implantology at the prestigious Harvard School of Dental Medicine as well as the University of Washington.

    She is currently Head of Clinic in the Periodontology and Oral Surgery Departement at the University of Liege. Her clinical work is focused exclusively on implantology, mucogingival surgery and periodontics. Her scientific research areas target different aspects of the use of biomaterial and dental implants

  • Geoffrey Lecloux

    Geoffrey Lecloux received a degree in dentistry at the University of Liege. After an assistantship, he received the title of specialist in oral rehabilitation. He specialized in the field of Periodontology and trained at the DU of Paris VII University. He also received the Implant and Periodontology Specialist degree at the University of Liege.

    He is currently Head of Clinic in the Prof. Rompen’s Periodontology Dental Surgery service.

Board of Directors

  • Marc Foidart

    CHAIRMAN

  • Simon Alexandre

    NON-EXECUTIVE

  • Thomas Lienard

    NON-EXECUTIVE, INDEPENDENT

  • Prof. Eric Rompen

    NON-EXECUTIVE, CO-FOUNDER